comparemela.com

Acg 2023 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Andreas Kremer, MD, PhD, MHBA: Seladelpar for the Treatment of PBC

Kremer discusses new ad hoc findings from the phase 3 ENHANCE trial showing seladelpar's unique effect on pruritus in patients with PBC.

United statesBritish columbiaResearchgate andreas kremerAndreas kremerUniversity hospital zurichAmerican college of gastroenterologyAmerican collegeScientific meetingPrimary biliary cholangitisPhase 3Acg 2023

Oral Biotherapeutic ADS024 Safe, Tolerable for Recurrent C difficile Prevention

New phase 1B data support further investigation into Adiso Therapeutic's prospective treatment.

United kingdomBritish columbiaJessicar allegrettiHarvard medical schoolAmerican college of gastroenterologyAmerican collegeScientific meetingAdiso therapeuticsC difficileInfectious diseaseAcg 2023

Etrasimod Significantly Benefits Ulcerative Colitis Regardless of Corticosteroids

New data from ACG 2023 shows etrasimod-treated patients were able to achieve UC remission, with or without concomitant steroid treatment at baseline.

British columbiaBrucee sandsIcahn school of medicine at mount sinaiAmerican college of gastroenterologyAmerican collegeScientific meetingIcahn schoolMount sinaiPbruce sandsElevate ucPhase 3Acg 2023

Guselkumab Benefits Ulcerative Colitis Regardless of Patient Treatment History

New QUASAR analysis shows patients with intolerance or failed response to advanced therapies nonetheless achieved benefit with guselkumab.

British columbiaLinkedin brian bresslerBrian bresslerAmerican college of gastroenterologyAmerican collegeScientific meetingAcg 2023Ulcerative colitisPhase 3

Autoimmune Hepatitis at ACG 2023, with Gina Choi, MD

The UCLA hepatologist discusses the current treatment landscape, prospects for improved diagnostics, and the overlap syndrome live from ACG 2023.

British columbiaGina choiAmerican college of gastroenterologyAmerican collegeAnnual scientific meetingAcg 2023Autoimmune hepatitisOverlap syndromeLiver disease

vimarsana © 2020. All Rights Reserved.